Inventor · disambiguated record
Thomas A. Natoli
Also filed as: NATOLI THOMAS · NATOLI THOMAS A
7 granted patents·3 pending applications·63 citations·filing 2008–2024
85Inventor score
Top patents by PatentIndex Score
10 records- 0192US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0288US8389517B2Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular diseaseIBRAGHIMOV-BESKROVNAYA OXANA·Filed 2009·Granted Mar 5, 2013·27 cites·22 claims
- 0387US8729075B2Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular diseaseGENZYME CORP·Filed 2013·Granted May 20, 2014·14 cites·24 claims
- 0486US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 0586US8912177B2Method of treating polycystic kidney diseases with ceramide derivativesNATOLI THOMAS A·Filed 2008·Granted Dec 16, 2014·8 cites·13 claims
- 0683US9481671B2Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular diseaseGENZYME CORP·Filed 2014·Granted Nov 1, 2016·7 cites·23 claims
- 0782US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 0868US2015216872A1Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2014·Application pending·0 cites
- 0957US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 1055US10220039B2Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Thomas A. Natoli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →